AzTrials
AzTrials

ArthrosisORTOMOVENCT07840391

Changes in Physical Activity, Sleep and Knee Function After Same-Day Discharge Knee Arthroplasty

An observational study of Arthrosis, run by Turku University Hospital at 2 sites in Finland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to examine changes in physical activity, sleep quality, knee extension and flexion strength, knee range of motion, and patient-reported outcomes before and after same-day discharge knee arthroplasty (SDD-KA). Read more about this study

Who is it for?
Ages Up to 80 years
Conditions the study is for
Arthrosis
What is being tested?
Medial unicompartmental knee arthroplasty (UKA) and Total knee arthroplasty (TKA)
Type of treatment
Surgery or procedure
How many people
120 participants
Where
2 sitesFinland
Study dates
1 Aug 2025to Feb 2029
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 80 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: The study population consists of patients undergoing same-day discharge primary knee arthroplasty: medial UKA or TKA according to standard clinical practice at Turku University Hospital. The choice of procedure is made on clinical grounds by the treating surgeon and is not influenced by study participation. Operations are performed by experienced arthroplasty surgeons under spinal anaesthesia following the hospital's standardized same-day discharge protocol.

Who may be able to join

  • Primary knee osteoarthritis: medial or lateral Kellgren Lawrence grade 3-4 for TKA and antero-medial grade 3-4 for UKA.
  • Patient criteria for outpatient knee arthroplasty (UKA or TKA):
  • Full overnight support by an adult at home after discharge
  • At most mild, well-controlled, comorbidities (e.g. hypertension, hypothyroidism, epilepsy, asthma)
  • ASA-class 1-2
  • Age <80 years
  • BMI <35 kg/m2

Who cannot join

  • Post-traumatic osteoarthritis
  • Neurological disorder aVecting walking or muscle strength
  • Inability or unwillingness to use a smartphone or to participate in the study
  • History of cardiac or cerebrovascular events
  • Conditions affecting consciousness (e.g. syncope of cardiac origin)
  • Untreated or central sleep apnoea
Show all 13Show fewer
  • Heart failure
  • Diabetes mellitus type 1
  • Cognitive impairment or dementia
  • History of substance abuse
  • Chronic strong opioid therapy or severe pain disorder
  • Antithrombotic therapy (e.g. Xarelto, Pradaxa, Plavix or ASA for secondary prevention)
  • History of venous thromboembolism or known coagulopathy

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Matias Hemmilä, Ph.D. contact

+358440607840

mmhemm@utu.fi

Juuso Hannula, Ph.D. student contact

+358505017676

juaukh@utu.fi

Finland2 sites, 2 recruiting
  • The UKK Institute for Health Promotion Research

    Tampere

    Tommi Vasankari, Title of Docent, +358405059157, tommi.vasankari@ukkinstituutti.fi

    Recruiting
  • Turku University Hospital

    Turku

    Matias Hemmilä, Ph.D., +358440607840, mmhemm@utu.fi

    Recruiting

Other trials in Finland

About this study

Official title: ORTOMOVE: Protocol for a Prospective Cohort Study Comparing Physical Activity, Sleep Quality and Patient-reported Outcomes Following Same- Day Discharge Knee Arthroplasty

The goal of this observational study is to examine changes in physical activity, sleep quality, knee extension and flexion strength, knee range of motion, and patient-reported outcomes before and after same-day discharge knee arthroplasty (SDD-KA). The study will also investigate whether these changes are associated with each other and with patient satisfaction. As a prespecified secondary aim, researchers will compare these outcomes between patients undergoing medial unicompartmental knee arthroplasty (UKA) and total knee arthroplasty (TKA).

The main questions it aims to answer are:

Read more
  • How do physical activity, sleep quality, knee extension and flexion strength, knee range of motion, and patient-reported outcomes change following SDD-KA?
  • Are changes in these outcomes associated with each other and with patient satisfaction?
  • Are these outcomes different between patients undergoing medial UKA and TKA?

Participants will:

  • Wear an accelerometer to measure physical activity and sleep before surgery, continuously from surgery to 3 months after surgery, and again for 2 weeks at 12 months after surgery
  • Complete questionnaires about knee function, sleep quality, pain, health-related quality of life, and satisfaction with surgery
  • Have knee muscle strength and active knee range of motion assessed before and 12 months after surgery
  • Attend follow-up assessments during the 12-month postoperative period
Read the detailed description

This is a prospective observational cohort study investigating postoperative recovery in patients undergoing same-day discharge knee arthroplasty (SDD-KA) for knee osteoarthritis. The primary aim is to characterize pre- to postoperative changes in physical activity, sleep quality, knee extension and flexion strength, knee range of motion, and patient-reported outcomes, and to investigate associations among these changes and their relationship with patient satisfaction.

As a prespecified secondary aim, the study will compare these outcomes between patients undergoing medial unicompartmental knee arthroplasty (UKA) and total knee arthroplasty (TKA). Patients are not randomized to UKA or TKA; the surgical procedure is determined by the treating clinical team according to established clinical indications. The study therefore represents an observational comparison of two patient cohorts undergoing different surgical procedures.

The study will include 120 patients undergoing primary SDD-KA at Turku University Hospital, Finland. The cohort will consist of 30 patients undergoing medial UKA and 90 undergoing TKA. Participants will be followed prospectively from the preoperative period through 12 months after surgery.

Physical activity and sleep will be assessed objectively using wearable accelerometers. Measurements will be performed during a two-week period before surgery, continuously from the time of surgery through 3 months postoperatively, and during a further two-week measurement period at 12 months postoperatively. Accelerometer data will be analysed at the UKK Institute for Health Promotion Research using validated algorithms. Clinical assessments will include isometric knee extension and flexion strength and active knee range of motion. Patient-reported outcomes will include knee-specific function, sleep quality, pain, health-related quality of life, and satisfaction with surgery. Assessments will be performed at predefined time points during the preoperative and postoperative follow-up period. The study is designed to provide an integrated assessment of recovery by combining objective wearable sensor-derived measures with standardized clinical assessments and patient-reported outcomes.

After completion of the 12-month follow-up, the data will be analysed by the study statistician. Baseline characteristics and outcome measures will be summarized descriptively. The primary analysis will evaluate the change in Oxford Knee Score (OKS) from baseline to 12 months in the whole cohort. As a secondary analysis, the change in OKS will be compared between the UKA and TKA groups.

Changes in outcomes over time will be assessed using linear mixed-effects models, where appropriate. Associations between physical activity variables, knee extension and flexion strength, range of motion and OKS will be assessed using models with a patient-level random effect for OKS, and with physical activity, strength, range of motion, time point and potential confounders as fixed effects. The patient-level random effect allows for handling the situations where some patients may have data missing at some time point, thus reducing the potential impact of dropout on the results. Potential confounders, including age, sex, body mass index, and ASA physical status classification, will be considered in the analyses. Multivariable regression analyses will also be used to examine associations between changes in the outcome measures.

As treatment allocation is based on clinical indication rather than randomisation, the UKA and TKA groups are expected to differ in baseline characteristics. Comparisons between the groups will therefore be adjusted for baseline characteristics, and residual confounding cannot be excluded. No adjustment for multiple comparisons will be made; analyses of secondary outcomes are considered exploratory and will be interpreted accordingly. Results will be presented with 95% confidence intervals. Statistical significance will be set at p<0.05.

Data will be collected prospectively according to a predefined study protocol. Clinical assessments and questionnaires will be performed using standardized procedures, and wearable sensor data will be collected according to the predefined measurement schedule. Data quality will be monitored through review of collected study data and checks for completeness and consistency. Missing or incomplete measurements will be documented and handled according to the prespecified statistical analysis plan.

The study will increase understanding of modifiable factors associated with recovery and satisfaction after KA. The findings may inform patient selection and support the optimisation of postoperative rehabilitation, and may help identify factors influencing recovery and surgical outcomes. Furthermore, the results may provide a foundation for designing interventions aimed at increasing postoperative mobilisation and physical activity, potentially using activity monitors to support optimal recovery, and may guide the design of future comparative studies.

Conditions
Arthrosis
Being tested
Medial unicompartmental knee arthroplasty (UKA), Total knee arthroplasty (TKA)
Keywords
Knee arthroplasty, Partial Knee replacement, Same-day discharge, Patient reported outcomes, Physical activity, Sleep
Medical subject headings
Osteoarthritis, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Medial unicompartmental knee arthroplasty (UKA)Procedure or surgery

    Primary medial UKA performed as part of routine clinical care for knee osteoarthritis. The procedure is not assigned by the study.

  • Total knee arthroplasty (TKA)Procedure or surgery

    Primary TKA performed as part of routine clinical care for knee osteoarthritis. The procedure is not assigned by the study.

Study groups in NCT07840391
Study groupRoleWhat they receive
Medial unicompartmental knee arthroplasty (UKA)Patients undergoing primary same-day discharge medial unicompartmental knee arthroplasty (UKA) for knee osteoarthritis. The medial UKA group will include 30 participants. The surgical procedure is determined by the treating clinical team according to established clinical indications and is not assigned by the study.
Receives: Procedure: Medial unicompartmental knee arthroplasty (UKA)
Total Knee Arthroplasty (TKA)Patients undergoing primary same-day discharge total knee arthroplasty (TKA) for knee osteoarthritis. The TKA group will include 90 participants. The surgical procedure is determined by the treating clinical team according to established clinical indications and is not assigned by the study.
Receives: Procedure: Total knee arthroplasty (TKA)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxford Knee Score (OKS)

    A 12-item patient-reported questionnaire assessing knee pain and function during daily activities. Each item is scored from 0 to 4, giving a total score ranging from 0 to 48. Higher scores indicate better knee function and less pain.

    Measured: The OKS will be completed by participants at baseline before surgery and at 3 and 12 months after surgery. The primary outcome is the change in OKS from baseline to 12 months after surgery.

Secondary outcomes (8)
  1. Objectively measured physical activity (sensor)

    Physical activity will be assessed objectively using a wearable accelerometer worn by participants during daily life. The accelerometer will continuously record movement during the predefined measurement periods. Physical activity will be characterized using accelerometer-derived measures of activity, including time spent at different levels of physical activity and daily activity patterns.

    Measured: Measurements will be performed during a two-week period before surgery, continuously from surgery to 3 months postoperatively, and during a further two-week period at 12 months after surgery.

  2. Objectively measured sleep (sensor)

    Sleep will be assessed objectively using a wearable accelerometer worn by participants during daily life. Sleep-related measures will be derived from accelerometer recordings during the predefined measurement periods. Sleep measures will be used to characterize changes in sleep patterns.

    Measured: Measurements will be performed during a two-week period before surgery, continuously from surgery to 3 months postoperatively, and during a further two-week period at 12 months after surgery.

  3. Isometric knee extension and flexion strength

    Isometric knee extension and flexion strength will be assessed using a standardized strength measurement procedure. Participants will perform a maximal voluntary isometric knee extension and flexion contraction, and the maximal force produced will be recorded. Higher values indicate greater knee muscle strength.

    Measured: Measurements will be performed before surgery and at 12 months after surgery.

  4. Knee range of motion

    Active knee range of motion will be assessed by measuring knee flexion and extension using a standardized clinical measurement procedure. Knee range of motion will be recorded in degrees. Greater knee flexion and less limitation in knee extension indicate better knee mobility.

    Measured: Measurements will be performed before surgery and at 12 months after surgery.

  5. Jenkins Sleep Scale (JSS)

    The Jenkins Sleep Scale (JSS) is a 4-item patient-reported questionnaire assessing the frequency of common sleep problems during the previous month. Each item is scored from 0 to 5, giving a total score ranging from 0 to 20. Higher scores indicate more frequent sleep problems and poorer sleep quality.

    Measured: The JSS will be completed at 2 weeks preoperatively and 12 months postoperatively.

  6. Pain -visual analogue scale (VAS)

    Pain intensity will be assessed using a visual analogue scale. Participants will rate their pain on a continuous scale from 0 to 100 mm, where 0 indicates no pain and 100 indicates the worst pain imaginable. Pain will be assessed both at rest and during movement. Higher scores indicate greater pain intensity.

    Measured: Measurements will be performed before surgery, 3 and 12 months after surgery.

  7. Health-related quality of life

    Health-related quality of life will be assessed using the 15D questionnaire, a standardized patient-reported measure covering 15 dimensions of health, including mobility, physical functioning, pain, sleep, and mental well-being. The 15D produces a single index score ranging from 0 to 1, where 0 represents the worst possible health state and 1 represents the best possible health state. Higher scores indicate better health-related quality of life.

    Measured: The questionnaire will be completed preoperatively, 3 and 12 months postoperatively.

  8. Patient satisfaction

    Patient satisfaction with the outcome of knee arthroplasty will be assessed using a 5-point Likert scale. Participants will rate their overall satisfaction with the result of surgery, ranging from very dissatisfied to very satisfied. Higher scores indicate greater satisfaction with the surgical outcome.

    Measured: Satisfaction will be assessed at 3 and 12 months postoperatively.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Sep 2026
  2. Study start1 Aug 2025
  3. Primary completionFeb 2029 (estimated)
  4. Study completionFeb 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07840391
Sponsor's protocol ID
/28406/13.02.02/2024
Acronym
ORTOMOVE
Status last verified
Sep 2026
First submitted
18 Sep 2026
Last updated
25 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There is currently no plan to make individual participant data (IPD) available to other researchers. The study will collect individual-level clinical, patient-reported, and wearable sensor data, and any sharing of such data would be subject to applicable data protection requirements, ethical considerations, and institutional policies.

Questions about this trial

What is this clinical trial studying?

An observational study of Arthrosis, run by Turku University Hospital at 2 sites in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 25 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Matias Hemmilä, Ph.D. (+358440607840, mmhemm@utu.fi), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxford Knee Score (OKS) (time frame: The OKS will be completed by participants at baseline before surgery and at 3 and 12 months after surgery. The primary outcome is the change in OKS from baseline to 12 months after surgery.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in